Sunil Shah

Sunil Shah has had a long and successful career in the business world. Sunil is currently a Board Observer at Metrion Biosciences, and has previously held positions at the Cambridge Judge Business School, the BioIndustry Association, and Metrion Biosciences. Sunil has also been a part of the Cambridge Angels and Oxford Drug Design. EXONATE LIMITED, Alevin Therapeutics Ltd, and Opal Therapeutics Limited are also companies where Shah has left their mark. Most recently, they were with o2h group. Throughout their many years of experience, Shah has demonstrated their ability to lead and grow businesses. Sunil is a well-respected figure in the business community, and their advice is often sought out by others looking to achieve success.

Sunil Shah has an MBA from the University of Cambridge and a BSc in Biochemistry and Management Sciences from Keele University.